Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic

Radiother Oncol. 2021 Jan:154:274-275. doi: 10.1016/j.radonc.2020.11.015. Epub 2020 Nov 21.

Authors

Naoya Murakami¹, Satoshi Nakamura², Tairo Kashihara³, Koji Inaba³, Tomoya Kaneda³, Kana Takahashi³, Kae Okuma³, Hiroshi Igaki³, Jun Itami³

Affiliations

¹ Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: namuraka@ncc.go.jp.
² Department of Medical Physics, National Cancer Center Hospital, Tokyo, Japan.
³ Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.

No abstract available

Keywords: COVID-19 pandemic; High dose-rate interstitial brachytherapy; Prostate cancer; Radiotherapy.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment